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In Brief
Mechanisms sensing when a sufficient number of immune cells have accumulated in tissues to terminate inflammation are incompletely understood. Here, Postat et al. establish that NO produced at inflammatory sites acts as a quorum sensing mechanism to adjust monocyte-derived cell respiration and cytokine production to their density in the tissue.
INTRODUCTION
Infection with pathogens and tissue damage triggers inflammation, a dynamic process aimed at protecting the injured host. Soluble mediators produced in particular by macrophages and mast cells actively increase vascular permeability and attract immune cells with antimicrobial properties (Medzhitov, 2008) . However, overwhelming inflammation may be responsible for severe immunopathology often due to excessive neutrophil accumulation. Mechanisms to terminate inflammation are therefore essential for balancing antimicrobial activity and tissue damage.
While the decrease in pathogen load or injury may help limit inflammation, active mechanisms implicating immune cells and mediators have also been shown to suppress the inflammatory reaction (Ortega-Gó mez et al., 2013; Sugimoto et al., 2016) . These include processes to decrease neutrophil activity and numbers through induction of apoptosis and increased clearance, mechanisms to regulate cytokine and chemokine activity by reactive oxygen species (ROS) generation or through truncation and sequestration by decoy receptors. Additionally, macrophage transition from a pro-inflammatory to a pro-resolving state represents an important step for terminating immune responses. Despite this important knowledge, mechanisms that select the appropriate time for inflammation resolution are poorly understood. Specifically, whether a mechanism exists to sense when a sufficient number of immune cells have accumulated to elicit the termination of inflammation remains unknown.
To address these questions, we took advantage of the selfresolving cutaneous infection with Leishmania major parasites (Sacks and Noben-Trauth, 2002; Scott and Novais, 2016 ) as a physiological model to study inflammation termination. Local infection with this intracellular pathogen triggers the massive recruitment of monocyte-derived mononuclear phagocytes (hereafter referred to as monocyte-derived cells) that not only represents the major populations of infected cells but also are actively involved in fighting the infection (De Trez et al., 2009; Leó n et al., 2007; Olekhnovitch et al., 2014) . Efficient immune responses indeed rely on inducible nitric oxide synthase (iNOS, NOS2)-mediated nitric oxide (NO) production by monocyte-derived cells, promoted by interferon-g (IFN-g)-producing CD4 + T cells (Olekhnovitch and Bousso, 2015; Sacks and Noben-Trauth, 2002; Scott and Novais, 2016) . NO production has a direct effect on the parasite, limiting its proliferation and survival (Liew et al., 1990; M€ uller et al., 2013) . However, decreasing parasite load may not be sufficient to stop the inflammatory reaction, raising the possibility that additional mechanisms acting on immune cells are important to terminate the response. Notably, NO displays immunoregulatory properties (Bogdan, 2001; Giustizieri et al., 2002; Kobayashi, 2010; Lu et al., 2015; Mishra et al., 2013; Speyer et al., 2003; Thomassen et al., 1997) , suggesting that it can act not only on the pathogen but also on inflammatory cells at the site of infection. In addition, recent studies have indicated that NO can modify cellular metabolism in in vitro settings (Everts et al., 2012; Van den Bossche et al., 2016) . However, by which mechanisms NO could influence the inflammatory response in vivo remains to be fully established.
In particular, the relevance of NO impact on metabolism in vivo has yet to be demonstrated. Finally, the spatiotemporal activity of NO in tissues is largely unknown.
Here, we have shown that NO production acts to adjust and limit the intensity of the inflammatory response. We have established that NO suppresses monocyte-derived cell accumulation as well as cytokine and chemokine production by blocking cellular respiration and decreasing ATP:ADP ratio. Such mechanism required a high density of recruited iNOS-expressing cells and acted at the tissue level through NO diffusion. Thus, monocyte-derived cells not only produce NO but also are regulated in number and activity by the amount of this molecule in the environment, establishing a quorum sensing mechanism for the control of inflammatory responses.
RESULTS

NO Dampens the Inflammatory Reaction at the Site of L. major Infection
During infection with intracellular pathogens, host NO can exert pleiotropic effects influencing immune responses at multiple stages (Bogdan, 2015; Olekhnovitch and Bousso, 2015) . To specifically evaluate the impact of NO production on an established inflammatory reaction, we assessed the consequence of a short period of iNOS inhibition in L. major-infected mice ( Figure 1A ). We used the specific iNOS chemical inhibitor L-NIL and treated mice 2 weeks after infection for 3 days. We found that iNOS inhibition profoundly increased myeloid cell numbers at the site of infection, with a major effect on neutrophils and monocyte-derived cells ( Figure 1B , 2007; Olekhnovitch et al., 2014) . All three populations of mononuclear phagocytes were substantially increased upon a short inhibition of iNOS ( Figure 1B ). To extend these results, we used Lyz2 +/EGFP mice (in which both neutrophils and macrophages are labeled with GFP) to visualize the effect of iNOS inhibition on myeloid cell density at the site of infection. Consistent with our flow cytometric analysis, two-photon imaging of the ear dermis revealed a significant increase in the density of myeloid cells (GFP + ) upon transient iNOS inhibition ( Figure 1C ). We next investigated the effect of iNOS inhibition on the inflammatory milieu at the site of infection by analyzing cytokine and chemokine concentrations in total ear tissue. We observed an overall increase in cytokine concentrations when iNOS activity was blocked. The effect appeared very broad and concerned most of the cytokines tested, including IL-1a, IL-1b, TNF-a, IL-6, IL-12 (p40 and p70), IL-10, IL-5, and IL-4 ( Figure 1D ). Similarly, iNOS inhibition led to a dramatic increase in chemokine concentrations in the ear tissue, including CXCL1, CXCL10, CCL2, and CCL3 ( Figure 1D ). Altogether, our results indicate that NO production at the site of L. major infection controls, either directly (acting on cells) or indirectly (acting on the pathogen), the inflammatory reaction, limiting immune cell infiltrates together with cytokine and chemokine concentrations.
NO Impacts Myeloid Cell Recruitment at the Site of L. major Infection To specifically assess the role of NO on immune cell recruitment at the site of infection, we performed adoptive transfer of myeloid populations by injecting fluorescently labeled bone marrow cells in infected mice. Cell recruitment in the infected ear was assessed in the presence or absence of iNOS inhibition ( Figure 2A ). Using intravital imaging, we detected the recruitment of transferred cells at the site of infection with a marked increase in GFP + cell numbers upon suppression of iNOS activity ( Figure 2B ). We confirmed this result using flow cytometry with a significant enhancement of myeloid cell (including neutrophils) recruitment upon iNOS inhibition (Figure 2C) . Notably, a sizable fraction ($6%) of newly recruited cells including neutrophils and monocyte-derived cells became infected in WT mice during this short window of time (Figure 2D) . Our results suggest that the constant recruitment of myeloid cells contributes to fuel L. major infection and, most importantly, that iNOS activity limits such a self-sustained process.
NO Restricts Monocyte-Derived Cell Function
In Vivo at the Single-Cell Level Having shown that NO limits the overall cytokine production in the infected tissue, we asked whether this effect was uniquely due to a reduced accumulation of cytokine-producing immune cells or whether NO exerted an additional effect on immune cell activity. We focused on monocyte-derived cells (the major population of myeloid cells at the site of infection) and analyzed cytokine production at the single-cell level, in infected mice upon transient inhibition of iNOS ( Figure 3A ). As shown in Figures 3B  and 3C , we observed an increased percentage of TNF-a-producing cells as well as an increased cytokine production on a per cell basis in infected mice in which iNOS activity was suppressed. This effect was not specific to TNF-a since we obtained similar results by analyzing the production of two other cytokines, pro-IL-1b and CCL3 ( Figure 3C ). Similar effects were observed when either total or infected cells were analyzed (Figures S1A and S1B). These results indicate that NO produced by monocyte-derived cells at the site of infection dampens their ability to produce cytokines and chemokines. When assessing the effects of L-NIL treatment, we found that a 3-day inhibition of iNOS also increased the percentage of infected monocytederived cells (Figures S1C and S1D) . While this could be the result of the increased immune cell recruitment at the site of infection, it could also reflect NO antimicrobial activity. Therefore, it was important to test whether NO mediated its effects indirectly by influencing pathogen load or by direct alteration of cellular activity. To test the latter possibility, we analyzed how NO affects monocyte-derived cell activity in a non-infectious model of inflammation using emulsified incomplete Freund's adjuvant ( Figure S2A ). In this model, we observed massive recruitment of myeloid cells including the three aforementioned mononuclear phagocytes populations (P1, P2, P3) and a robust induction of iNOS (Figures S2B and S2C) . Importantly, treatment with L-NIL increased monocytederived cell activity as measured by TNF-a, CCL2, and CCL3 production ( Figure S2D ). These results suggest that NO can Results are representative of 6 independent experiments. Data are represented as mean ± SD.
restrict monocyte-derived cell activity independently of any potential effect on pathogen burden.
NO Broadly Restricts Bone MarrowDerived Macrophage Functions
In Vitro To further confirm and dissect the direct effect of NO on immune cells, we activated WT or Nos2 À/À bone marrow-derived macrophages in vitro and in the absence of pathogen with LPS+IFN-g, a treatment that induces iNOS expression in WT cells. As shown in Figure 4A , LPS+IFN-g treatment induced the intracellular production of the tested cytokines (pro-IL-1b and CCL2) in both WT and Nos2 À/À macrophages. However, cytokine production was significantly higher in Nos2 À/À macrophages. We repeated these experiments by treating WT macrophages with L-NIL to suppress NO production in order to exclude any potential additional defect of cells isolated from Nos2 À/À mice. Consistently, we observed higher production of pro-IL-1b and CCL2 in the presence of iNOS inhibition ( Figure 4B ). As expected, L-NIL had no effects on Nos2 À/À macrophages or on WT unactivated macrophages ( Figure S3 ). We extended the aforementioned results obtained with intracellular cytokine staining by performing multi-analyte cytokine profiling on macrophage supernatants. Reflecting the effect of iNOS inhibition during L. major infection, Nos2 À/À macrophages exhibited an overall increased production of inflammatory cytokines and chemokines, including IL-1a, IL-1b, IL-6, CXCL10, CCL2, and CCL3 ( Figure 4C ). These results suggest that NO acts on macrophages to limit cytokine and chemokine production both in vitro and in vivo.
NO Blockade of Mitochondrial Respiration Restricts ATP:ADP Ratio and Macrophage Activity
Given the broad suppression of cytokine production by NO, we asked whether this effect could originate from a change in cellular metabolism (Biswas and Mantovani, 2012; Everts et al., 2012; Lu et al., 2015; Na et al., 2018; Sancho et al., 2017; Thwe and Amiel, 2018; Van den Bossche et al., 2016 . Consistent with this idea, we observed that WT macrophages engage glycolysis but stop relying on oxidative phosphorylation upon activation as measured by decreased basal respiration and ATP synthesis (Figures 5A and 5B) . By contrast, Nos2 À/À macrophages used both respiration and glycolysis upon activation ( Figures 5A and 5B). Overall, glycolytic activity and glucose uptake were not affected by iNOS activity ( Figure S4 ). Similarly, blocking iNOS activity with L-NIL in WT macrophages restored their respiratory capacity when activated ( Figure 5C ). To confirm these findings at the single-cell level, we used a combination of dyes to measure total (MitoTracker GreenFM) and respiring (MitoTracker Red CMXRos) mitochondria by flow cytometry. A drop in cell respiration was seen upon activation of WT but not 
Nos2
À/À macrophages ( Figure S5A ). Again, blocking iNOS activity in WT macrophages was sufficient to restore respiration ( Figure S5B ). To test whether these findings pertain to monocyte-derived cells in vivo at the site of L. major infection, we sorted monocyte-derived cells from the ears of infected WT mice and subjected them to metabolic flux analysis in the presence or absence of L-NIL. As observed with in vitro macrophages, ex vivo-isolated WT monocyte-derived cells displayed a block in respiration that was relieved by a short incubation (2 hr) with L-NIL ( Figure 5D ). These results demonstrate that NO production by macrophages drastically suppresses their respiratory capacity, in both bone marrow-derived macrophages and monocyte-derived cells at the site of infection.
To further characterize the impact of NO on cellular metabolism, we relied on PercevalHR, a genetically encoded fluorescent probe for monitoring ATP:ADP ratio, hence providing a readout for the energetic status of individual cells in real time (Tantama et al., 2013) . Upon NO exposure, we observed a drop in ATP:ADP ratio in activated and L-NIL-treated PercevalHR-expressing macrophages within less than 10 min, as measured by time-resolved flow cytometry ( Figure 6A ). These findings were confirmed by following individual PercevalHR-expressing macrophages using live imaging ( Figure 6B ). Thus, one important consequence of NO targeting of mitochondrial respiration is the rapid and substantial reduction in the cellular ATP:ADP ratio. We next ask whether such energetic changes could explain the reduced cytokine production in macrophages exposed to NO. We therefore specifically inhibited the ATP synthase using oligomycin (that targets the F0 subunit of the ATP synthase). We noted that oligomycin treatment induced a drop in ATP:ADP ratio similar to that observed with NO ( Figures 6C and 6D ). Most importantly, a short-term (4 hr) inhibition of ATP synthase in macrophages was sufficient to reduce cytokine and chemokine production as measured by intracellular cytokine staining ( Figure 6E ) and multi-analyte cytokine profiling (Figure 6F) . Similar results were observed by performing the experiment in hypoxic condition ( Figure S6A ) or by blocking respiration with azide that targets complex IV of the mitochondrial respiratory chain, which activity precedes that of the ATP synthase ( Figure S6B ). Together, our results support the idea that NO blockade of mitochondrial respiration rapidly diminishes the cellular energetic resources required for optimal cytokine production. To test whether NO also affect the ATP:ADP ratio in vivo during infection, we generated chimeric mice by transducing HSCs with PercevalHR and infected them with L. major ( Figure 6G ). Two weeks later, we measured the ATP:ADP ratio in monocyte-derived cells at the infection site in mice treated or not with L-NIL. We observed that iNOS inhibition largely increased cellular ATP:ADP ratio in both P2 and P3 populations ( Figure 6H ), supporting the relevance of our model during inflammation in vivo. 
Collective NO Production Provides a Quorum Sensing Mechanism to Dampen Chronic Inflammation
We next sought to clarify how NO acts in the infected tissue. NO could act in a cell-autonomous manner, suppressing the respiration of individual NO-producing cells or act more broadly by diffusing in the tissue. In addition, it was unclear whether NO produced by a single cell has any biological activity or whether the collective production by numerous cells is essential to impact on cellular metabolism. We first addressed these questions in vitro by mixing iNOS-competent and -deficient macrophages at different ratios to generate distinct densities of NO-producing cells at a constant total cell number. We found that the block of cell respiration in macrophages increased with the density of NO-producing cells (Figures S5C-S5E ). Most importantly, only a modest block in cell respiration was seen in macrophages competent for NO production when these cells were present at low density (10:90 ratio), indicating that the effect on cellular metabolism was by large not cell intrinsic. Conversely, a block in respiration was detected in Nos2 À/À macrophages provided that they were surrounded by numerous iNOS-competent cells (50:50 ratio) ( Figures S5C-S5E) . Importantly, the same rules applied for cytokine and chemokine production ( Figures S5F and S5G) . Indeed, pro-IL-1b and CCL2 production was suppressed in both WT and Nos2 À/À macrophages mixed at 50:50 ratio. At lower ratio (10:90), pro-IL-1b and CCL2 production were largely unaffected even in WT macrophages. These results strongly suggest that the density of NO-producing cells plays a crucial role to regulate cell activity ( Figure S5 ).
To test this hypothesis in vivo, we generated mixed-bone marrow chimeras using various ratios of WT (CD45.1) and
Nos2
À/À (CD45.2) cells for reconstitution ( Figures 7A and 7B ) in order to establish varying densities of iNOS-competent cells at the infection site. The corresponding cellular densities were estimated by intravital imaging (Figures S7A-S7C ). Following infection with L. major, we assessed the activity of monocyte-derived cells isolated from the site of infection. Our results revealed that the amount of pro-IL-1b ( Figures 7C and S7D ) produced was regulated by the density of iNOS-competent cells. Moreover, the amounts of cytokine production were identical in WT (CD45.1) and Nos2 À/À (CD45.2) cells analyzed in the same environment, indicating that NO-mediated effect on cytokine production is not cell intrinsic but instead largely rely on NO diffusion in the tissue. Similar results were obtained analyzing TNF-a (Figures 7D and S7D) and CCL3 ( Figures 7E and S7D ) production. Therefore, NO mediates the downregulation of the inflammatory reaction only when a sufficient number of NO-producing cells have accumulated at the site of infection. We estimated that a density of approximately 5,000 iNOS-competent cells/mm 3 needs to be reached to substantially inhibit cytokine production ( Figure S7D ). Furthermore, NO acts at the tissue level through diffusion irrespectively of intrinsic iNOS expression. In sum, monocyte-derived cells that accumulate at the site of infection produce diffusible NO that will progressively inhibit further recruitment and inflammation as cell density increases. Monocyte-derived cells are therefore endowed with a metabolism-based quorum sensing mechanism to help control and terminate the immune response.
DISCUSSION
In the present report, we identified a novel mechanism that adjusts the intensity of the inflammatory reaction to the local density of monocyte-derived cells. Mechanistically, we have shown that nitric oxide decreased cellular respiration, ATP:ADP ratio, and cytokine and chemokine production, dampening myeloid cell recruitment and overall inflammation. Since NO was found to act only when a sufficient number of NO-producing cells have accumulated, these properties define a quorum sensing mechanism for the control and termination of inflammatory reactions.
In the context of infection with an intracellular pathogen, we confirmed that the role of NO extends beyond its well-known antimicrobial properties by profoundly influencing immune cell activity in vivo. Nos2 À/À mice have been previously shown to exhibit exacerbated immunopathology in response to infection with L. major or M. tuberculosis (Belkaid et al., 2000; Mishra et al., 2013 Mishra et al., , 2017 Wei et al., 1995) . Since iNOS deficiency may affect the initiation and development of the immune response, we used a short pharmacological inhibition of iNOS to reveal the role of NO specifically once the inflammatory reaction is established. Blocking NO production for 3 days was sufficient to boost monocyte-derived cell ability to secrete cytokines and chemokines at the single-cell level and to increase myeloid cell recruitment and accumulation. Such an enhanced recruitment of myeloid cells could possibly originate from factors derived from monocytes and/or neutrophils, two cell types that act in concert during inflammation (Dal-Secco et al., 2015; Kreisel et al., 2010; L€ ammermann et al., 2013) . In addition, NO could influence cell recruitment by modulating leukocyte adhesion and extravasation (Banick et al., 1997; Kubes et al., 1991) . These observations were recapitulated in in vitro-derived macrophages without pathogen in agreement with previous studies (Bogdan, 2001; Braverman and Stanley, 2017; Eigler et al., 1995; Giustizieri et al., 2002; Speyer et al., 2003; Thomassen et al., 1997) as well as in a non-infectious model of inflammation, suggesting that the observed effects of NO on the immune reaction were not simply due to indirect changes in the parasite. NO-mediated suppression of cytokine production can result from an alteration of inflammasome assembly (Mishra et al., 2013) or a decrease in NF-kB activity (Braverman and Stanley, 2017; Matthews et al., 1996) . Notably, in our model, NO appeared to decrease cytokine and chemokine production very broadly, affecting most type 1, type 2, and suppressive cytokines tested. The wide range of cytokines and chemokines downregulated by NO prompted us to investigate a global effect on cellular metabolism. NO has the ability to block the respiratory chain (Brown, 1999 (Brown, , 2001 Clementi et al., 1998) and iNOS induction has been shown to block respiration in dendritic cells and macrophages cultured in vitro (Van den Bossche et al., 2016) or in inflammatory dendritic cells stimulated ex vivo (Everts et al., 2012) . To extend these findings, we sought to determine whether blockade of respiration by NO could be observed in an ongoing immune response. By directly analyzing the metabolism of sorted monocyte-derived cells from the site of L. major infection, we showed that these cells exhibited a profound block in cell respiration that could be reversed by a short inhibition of iNOS. Using a genetically encoded reporter for ATP:ADP ratio (PercevalHR), we noted that NO decreased the cellular energetic yield both in vitro and in vivo. These observations establish the physiological relevance of NO-mediated alteration of cell metabolism in the context of a chronic inflammation with an intracellular pathogen. Importantly, we provide evidence that respiration blockade and decrease in ATP production are by themselves sufficient to limit cytokine and chemokine production, suggesting a causal link between NO-mediated respiration blockade and dampening of monocyte-derived cell activity.
While our data support a role for NO in reducing cytokine production by altering respiration and energetic yield, additional mechanisms could also contribute to limit inflammation. These include mitochondria-dependent mechanisms such as modulation of mitochondrial ROS (Mills et al., 2016) and/or concentrations of specific metabolites (e.g., succinate [Mills et al., 2016; Tannahill et al., 2013] and itaconate [Cordes et al., 2016; Lampropoulou et al., 2016; Michelucci et al., 2013] ) but also mitochondria-independent mechanisms such as modulation of NADPH oxidase-derived ROS (Bagaitkar et al., 2015; Harbort et al., 2015; Meissner et al., 2008; Morgenstern et al., 1997; Warnatsch et al., 2017) and/or alteration of the NF-kB pathway (Braverman and Stanley, 2017; Matthews et al., 1996) .
Collectively, results from this work and from other studies (Amiel et al., 2014; Everts et al., 2012; Van den Bossche et al., 2016) highlight the diverse effects of respiration blockade by NO on monocyte-derived cell biology, including alteration of survival capacity, plasticity, and inflammatory activity.
One key result of our study is that the impact of NO on monocyte-derived cell metabolism is not a cell-autonomous mechanism requiring intrinsic iNOS expression. Instead, it is the number of NO-producing cells in the microenvironment that determines the respiratory capacity of monocyte-derived cells at the tissue level, affecting similarly NO-producing and non-producing cells, most likely through diffusion. In other contexts, cytokine may similarly act both on producing and non-producing cells to coordinate heterogeneous populations in a given environment (Shalek et al., 2014) . We have previously observed such a dependency on collective NO production and NO diffusion to mediate antimicrobial activity (Olekhnovitch et al., 2014) . In vitro experiments have delineated the various impact of iNOS induction on macrophages and dendritic cells (Everts et al., 2012; Lu et al., 2015; Van den Bossche et al., 2016) . Our results suggest that it is important to consider that these effects are not necessarily cell autonomous and can vary drastically in vivo based on the density of iNOS-expressing cells in the microenvironment. In this respect, we estimated that the suppressive effects of NO were substantial when the density of monocyte-derived cells reached 5,000 cells/mm 3 in the skin. Quorum sensing mechanisms allow bacteria to sense and react to the density of their population, with the help of a Results were evaluated using a two-tailed unpaired Student's t test with Welch's correction. Data are represented as mean ± SD. See also Figure S6 . diffusible mediator termed auto-inducer (Miller and Bassler, 2001) . Similar mechanisms may exist in the immune system at homeostasis or during immune responses. For example, IgG secreted by activated B cells has been shown to regulate B cell homeostasis (Montaudouin et al., 2013) . Here, we show that monocyte-derived cells can modify their activity and recruitment by sensing their density through the release of the diffusible molecule NO. We therefore propose that quorum sensing is integral to the inflammatory reaction, allowing it to temporally control immune cell numbers and activity for optimal immune responses with limited immunopathology.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
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Bone marrow-derived macrophages (BMDMs) Femurs and tibias were isolated from adult WT or Nos2 À/À mice, sterilized in 70% ethanol and flushed with PBS. Single cell suspensions were prepared by filtering the marrow through a 30 mm cell strainer. 20 3 10 6 BMC were cultured in 150 mm non-treated Petri dishes for 7 days, 37 C, 5% CO 2 , in 30 mL RPMI medium 1640 -GlutaMAX TM supplemented with 10% heat-inactivated fetal bovine serum, 100 U/mL penicillin, 100 ng/mL streptomycin, 1 mM sodium pyruvate, 10 mM HEPES and 5 mM 2-mercaptoethanol (complete RPMI) and 20% L929-cell conditioned supernatant. 30 mL of fresh medium was added 3 days after plating.
METHOD DETAILS Infection, inflammation model and L-NIL treatment
For infection, stationary-phase promastigotes were resuspended at 10 8 parasites/mL in PBS and 5 mL were injected intradermally into the ear dermis. To induce a non-infectious inflammatory reaction, incomplete Freund's adjuvant was emulsified with an equal volume of saline and 10 mL were injected intradermally into the ear dermis. To inhibit iNOS activity, L-NIL was freshly prepared at 2 mg/mL in PBS and mice were injected with 100 mL i.p. once a day for 3 days, starting 14 days post infection or 4 days post challenge. Age and sex-matched controls were infected or challenged at the same time and did not received L-NIL injection.
Extraction of ear cells
Ears harvested from euthanized mice were separated into dorsal and ventral sheets using tissue forceps before being digested for 45 min, 37 C, 700 rpm, in RPMI medium 1640 supplemented with 100 U/mL penicillin, 100 ng/mL streptomycin, 0.5 mg/mL liberase TL and 50 ng/mL DNase. Single cell suspensions in PBS were prepared by crushing digested ears into a 70 mm cell strainer. After a washing step in PBS and filtration, cells were analyzed by flow cytometry or subjected to extracellular flux analysis.
Adoptive transfer
Bone marrow cells were harvested from Ubi-GFP mice and filtered through a 30 mm cell strainer to generate a single cell suspension. 6 3 10 7 cells were injected i.v. per mice after anesthesia.
Flow cytometry
In vitro generated BMDMs were washed with cold PBS and incubated for 10 min, 4 C, in 3 mL of Cell Dissociation Buffer to detach the cells. BMDMs were recovered by adding 10 mL of cold PBS and washed before seeding at 10 6 cells/well (6-well non-treated plates) in was maintained adding 20 mg/mL L-NIL to dedicated wells. Cells were harvested by flushing all wells and submitted to staining as described above. After surface staining, cells were permeabilized using PermWash buffer following manufacturer's instructions and stained 45 min, 4 C, using a combination of fluorescently-labeled monoclonal antibodies among: Alexa FluorÒ 488 anti-mouse TNF-a, eFluorÒ 660 anti-CCL3, APC anti-mouse IL-1b Pro-form. Samples were analyzed using a BD CantoII or a BD Fortessa flow cytometer equipped with FACSDiva software (BD Bioscience) or a CytoFLEX LX flow cytometer equipped with CytExpert software (Beckman Coulter).
For analysis of PercevalHR-expressing cells, two fluorescence signals were acquired. F low was collected by exciting PercevalHR with a violet laser (l low = 405 nm) and filtering the signal through a 525/40 filter. F high was collected by exciting PercevalHR with a blue laser (l high = 488 nm) and filtering the signal through a 510/20+OD1 filter. Cellular ATP:ADP ratio was determined by calculating F high :F low ratio for each acquired cell. For time-resolved (kinetic) flow cytometry, ATP:ADP ratio was normalized to the first value -acquired (t 0 ). Data analysis was performed using FlowJo 10.2 software.
MitoTracker staining
After activation, cells were loaded with MitoTrackerÒ dyes using 40 nM MitoTrackerÒ GreenFM and 50 nM MitoTrackerÒ Red CMXRos during 30 min, 37 C, 5% CO 2 . Cells were washed with cold PBS before flow cytometry analysis.
Hypoxic culture
Hypoxic cultures were conducted using PetakaG3 FLAT hypoxic devices (balancing the partial pressure of dissolved oxygen in the media at 25 mmHg). 15 3 10 6 BMDMs were loaded into each chamber in 20 mL complete RPMI supplemented with 20% L929-cell conditioned medium and cultivated horizontally overnight to allow cell seeding. The day after, medium was replaced for activation. Cell treatments and flow cytometry were performed as described earlier.
Extracellular flux analysis
BMDMs were analyzed using an XF e 96 Extracellular Flux Analyzer (Seahorse Bioscience). BMDMs were plated in XF e 96 cell culture microplates (10 5 cells/well in 200 mL final) and either left untreated or activated with 1 mg/mL LPS + 50 ng/mL IFN-g, 37 C, 5% CO 2 . 24 h post activation, cells were washed with XF Base medium supplemented with 10 mM glucose, 2 mM glutamine and 1 mM sodium pyruvate (MitoStress XF running buffer, pH adjusted to 7.4) or supplemented with 2 mM glutamine (GlycoStress XF running buffer, pH adjusted to 7.4), and 175 mL of appropriate XF running buffer was added as final volume. BMDMs were stored 1 h at 37 C in a non-CO 2 incubator before starting the analysis. Following manufacturer's instruction, OCR and ECAR were measured in response to 1 mM oligomycin, 1.5 mM Carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP) and 0.5 mM rotenone and antimycin A (MitoStress Test Kit) or in response to 10 mM glucose, 1 mM oligomycin and 50 mM 2-deoxy-glucose (2-DG) (GlycoStress Test Kit).
For ex vivo isolation of mononuclear phagocytes from infected ears, we relied on the expression of the CD11c marker on both P2 and P3 populations (Olekhnovitch et al., 2014) . CD11c + cells were isolated from infected ears using positive selection on MACS columns. The isolated population contained at least 90% of CD11b + MHC-II + monocyte-derived cells. Cells were washed and plated at 10 5 cells/well in 175 mL of MitoStress XF running buffer and treated with 20 mg/mL L-NIL or left untreated during 2 h, 37 C, non-CO 2 incubator. Following manufacturer's instruction, OCR and ECAR were measured in response to 1 mM oligomycin, 1.5 mM FCCP and 0.5 mM rotenone and antimycin A (MitoStress Test Kit). Data analysis was performed using Wave software.
Multiplex assay for cytokine and chemokine quantification Ears harvested from euthanized mice were separated into dorsal and ventral sheets and snap frozen before storage at À80 C until analysis. For tissue lysates preparation, ears were thawed out and chopped in 1 mL RIPA buffer on ice. After 20 min incubation, samples were grounded during 2 min with a Potter-Elvehjem PTFE pestle into an appropriate glass tube. Lysates were subsequently clarified by centrifugation for 15 min at 4 C, 15.000 rcf. Multiplex assay was performed following manufacturer's instructions. Lysates were diluted at 1:2 in assay diluent. Standards were reconstituted with RIPA buffer diluted at 1:2 in assay diluent. For analyte capture, the plate was incubated overnight at 4 C under agitation on an orbital shaker. Plate reading was performed using a Bio-Plex 200 system equipped with Bio-Plex Manager software (Bio-Rad).
For in vitro analyses, BMDMs were cultivated and activated as indicated during 24 h. Supernatants were harvested and cleared by centrifugation before being snap frozen and stored at À80 C until analysis. The day of analysis, supernatants were diluted 1:4 in assay diluent and multiplex assay was performed as described previously.
PercevalHR probe and virus generation
The original PercevalHR construct was cloned into a murine stem cell viral (MSCV) vector. HEK293 cells were co-transfected with 6 mg pMSCV-PercevalHR and 4 mg pCL-Eco plasmids using JetPRIME reagent following manufacturer instructions. Medium was changed 4 h after with complete RPMI. 48 h after transfection, retrovirus containing supernatant was harvested from HEK293 cells, 0.45 mm-filtered and supplemented with 10 mg/mL polybrene to generate retroviral-conditioned medium.
